2023-06-28 16:33:29 ET
- Aethlon Medical press release ( NASDAQ: AEMD ): FY GAAP EPS of -$0.59 beats by $0.04 .
- Revenue of $574.24M (+95.2% Y/Y).
- Professional fees for the fiscal year ended March 31, 2023 were $3.54 million compared to $2.63 million in the fiscal year ended March 31, 2022.
-
As of March 31, 2023, Aethlon Medical had a cash balance of approximately $14.5 million.
- Consolidated operating expenses for the fiscal year ended March 31, 2023 were approximately $12.47 million, compared to $10.71 million for the fiscal year ended March 31, 2022, an increase of approximately $1.76 million.
For further details see:
Aethlon Medical GAAP EPS of -$0.59 beats by $0.04, revenue of $574.24M